ORBISA INSIGHTS

| Take NOTES

LASER FOCUSED BUY SIDE DATA

TAKE NOTES

Orbisa ON Intercept Pharma

Orbisa provides robust metrics for the buy-side allowing market participants to validate their short positions. In our latest analytical piece, Orbisa insights shows a striking decline in borrowing demand for Intercept Pharmaceuticals. 

TAKE NOTES

Orbisa ON VICTORIA

Orbisa offers the buy-side unique intelligence by which to frame their market research and validate trading decisions with 37 curated data metrics. 

TAKE NOTES

Orbisa ON SSB

Keeping an eye on the latest publication from Viceroy Research?

Orbisa analysis of their latest investigative interest, Samhällsbyggnadsbolaget i Norden AB showed huge jumps in utilization, fee volatility and on loan value relating to SSB within days of Viceroy Research’s release alleging SSB of Governance problems, insider dealing and other worrying financial issues.

Orbisa offers the buy-side unique intelligence by which to frame their market research and validate trading decisions with 37 curated data metrics. 

TAKE NOTES

Orbisa ON EVERGRANDE

Orbisa offers a unique lens into the securities lending market for buy-side market participants. Each of our laser-focused, curated data metrics offers traders unique intelligence by which to frame their market research and validate trading decisions. 

We’ve analyzed the ongoing scenario in February 2022 with Evergrande (3333HK) in Orbisa. 

Take a look at the story told in the data.

contact us at

DiscoverMore@Orbisa.com

US: +1 (646) 767-4335
UK: +44 (0)203 023 8383
HK: +852 3622 3955
 

 © 2022 Orbisa LLC. Proprietary and Confidential. For discussion purposes only.